Insulin RegimensThe appropriate insulin regimen for each patient with diabetes will depend on their type of diabetes and their individual needs and circumstances. Improved glycaemic control has been shown to reduce the risk of complications for both type 1 diabetes and type 2 diabetes. Regimens which attempt to improve glycaemic control will require more active involvement of the patient, both with the number of injections and with the need for close self-monitoring of blood glucose.
How to Initiate, Titrate, and Intensify Insulin Treatment in Type 2 DiabetesThis article provides pharmacists with an overview of recent developments and currently available insulin therapies in the management of type 2 diabetes.
Long-Acting Insulin Analogues in Type 2 Diabetes Mellitus Long-acting insulin analogues have no advantages over human isophane insulin in effects on HbA1C levels. They have at best, marginal benefits on hypoglycaemic episodes.
Conversion of Glucose Values from mg/dl to mmol/l
HOMA CalculatorThe HOMA Calculator uses the HOMA2 model to estimate beta cell function (%B) and insulin sensitivity (%S) for an individual from simultaneously measured fasting plasma glucose and fasting plasma RIA insulin values. Fasting specific insulin or C-peptide values can be used instead of RIA insulin. The HOMA2 model is calibrated to give %B and %S values of 100% in normal young subjects when using a suitable insulin assay.
estimated Average Glucose, eAGADA is recommending the use of a new term in diabetes management, estimated average glucose, or eAG. Health care providers can now report A1C results to patients using the same units (mg/dl or mmol/l) that patients see routinely in blood glucose measurements.
HbA1c Standardisation For Clinical Health Care ProfessionalsFrom 1 June 2009, the way in which HbA1c results are reported in the UK is changing. This leaflet explains why and how this will happen.
HbA1c converterConvert HbA1c % to mmol/mol and vice versa
Reporting and interpreting glycated haemoglobin (HbA1c) results/values When performed for diagnosis/CV risk screening
The Association has developed three SMBG tools—one for healthcare providers and two for people living with diabetes—to not only identify SMBG recommendations and pattern management for healthcare providers, but to provide essential information and education for patients for optimal self-management.
Management of Hypertension for People with Diabetes Hypertension is a common problem in people with diabetes. This resource provides a summary for practicing clinicians about the treatment of hypertension in people with diabetes
European Society of Hypertension Newsletter
Urine Albumin-to-Creatinine Ratio (UACR) Evaluating Patients with Diabetes for Kidney Disease presents key information about assessing UACR and GFR for diabetes educators and other healthcare professionals.
UK Prospective Diabetes Study Risk EngineRisk calculators based on equations from the Framingham Heart Study tend to underestimate risks for people with diabetes as this study included relatively few diabetic subjects. The UKPDS Risk Engine is a type 2 diabetes specific risk calculator based on 53,000 patients years of data from the UK Prospective Diabetes Study, which also provides an approximate 'margin of error' for each estimate.
myhealthywaist.orgThe website myhealthywaist.org is produced by the International Chair on Cardiometabolic Risk of Université Laval. The most comprehensive educational website on the relationships between abdominal obesity, type 2 diabetes and cardiovascular disease.
Management of hyperglycemia in patients with diabetes mellitus and chronic renal failureDiabetes mellitus is recognized as a leading cause of chronic kidney disease and end-stage renal failure. Chronic renal failure is associated with insulin resistance and, in advanced renal failure, decreased insulin degradation. Both of these abnormalities are partially reversed with the institution of dialysis. Except for diet with protein restriction, patients with diabetes should be preferably treated with insulin.
Drug interactions with oral hypoglycaemic drugsOral hypoglycaemic drugs may interact with other drugs. Pharmacodynamic interactions occur with medications that alter blood glucose and may require the dose of the oral hypoglycaemic drug to be altered. Pharmacokinetic interactions vary with the drug group. Sulfonylureas and repaglinide are metabolised in the liver. Their plasma concentrations and activity can be reduced by drugs which induce hepatic enzymes and increased by hepatic enzyme inhibitors. Metformin is renally excreted and may have increased toxicity with drugs that impair renal function.
Oral Hypoglycemic Agents: The Risk of HypoglycemiaA number of studies and case reports have described clinically important drug interactions with oral hypoglycemics.
Rifamycins and Anti-Diabetic Agents: Drug-Drug Interactions A 2-sided diagram for clinicians and healthcare providers that describes drug-drug interactions of Rifamycins and Anti-Diabetic Agents.
Management of adults with diabetes undergoing surgery and elective procedures: improving standardsThese guidelines have been commissioned by NHS Diabetes and written by the Joint British Diabetes Societies Inpatient Care Group and representatives from the specialist societies surgeons and anaesthetists.
The peri-operative management of the adult patient with diabetes
|
 Source: asgbi.org.uk |
| Clinical Resource: Publication |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
| Source: rcht.nhs.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 27/08/13 | Link Error: Report It |
This article examines current information regarding vulvovaginitis in diabetic women and therapeutic options for its management.
| Source: diabetesjournals.org |
| Clinical Resource: Journal Article |
| Register to Access Content: No
|
| Last Checked: 08/05/13 | Link Error: Report It |
| Source: nutritioncare.org |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Caring for Diabetics in a Palliative Care setting; The challenges.
| Source: rbch.nhs.uk |
| Clinical Resource: Presentation |
| Register to Access Content: No |
| Last Checked: 24/04/14 | Link Error: Report It |
Diabetes Mellitus at the End of Life
| Source: hospiceintheweald.org.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 24/04/14 | Link Error: Report It |
British Thyroid Association Guidelines/Statements
| Source: british-thyroid-association.org |
| Clinical Resource: Guidelines |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
American Thyroid Association Professional Guidelines
| Source: thyroid.org |
| Clinical Resource: Guidelines |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Any physician may submit a question regarding a thyroid patient to <ldegroot@earthlink.net> and one of our panel of expert thyroidologists will attempt to provide an answer
| Source: thyroidmanager.org |
| Clinical Resource: Questions and Answers |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Contents
Indications for thyroid function testing
Hypothyroidism
Hyperthyroidism
| Source: pathlabs.rlbuht.nhs.uk |
| Clinical Resource: Summary |
| Register to Access Content: No |
| Last Checked: 13/03/14 | Link Error: Report It |
This Bulletin discusses the treatment of thyroid disease and considers approaches to diagnosis and monitoring.
| Source: npc.nhs.uk |
| Clinical Resource: National Prescribing Centre Bulletin |
| Register to Access Content: No |
| Last Checked: 24/04/15 | Link Error: Report It |
Thyroid dysfunction is a common disorder and most cases of hypothyroidism are managed in general practice. Our Drug review discusses the currently available drug treatments for hypo- and hyperthyroidism, followed by sources of further information in Resources.
| Source: eu.wiley.com |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Myxoedema coma is a rare, but potentially fatal disorder which may occur in patients with longstanding untreated hypothyroidism.
| Source: patient.co.uk |
| Clinical Resource: Article |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
The proper treatment of hyperthyroidism depends on recognition of the signs and symptoms of the disease and determination of the etiology. The most common cause of hyperthyroidism is Graves' disease. Other common causes include thyroiditis, toxic multinodular goiter, toxic adenomas, and side effects of certain medications.
| Source: aafp.org |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
This article outlines the clinical presentation and evaluation of a patient with thyrotoxicosis.
| Source: racgp.org.au |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Hyperthyroid crisis is an uncommon medical emergency caused by an exacerbation of hyperthyroidism characterised by decompensation of one or more organ systems in people with untreated or poorly treated hyperthyroidism. Hyperthyroid crisis usually occurs in patients already known to have hyperthyroidism but may be the first presentation of hyperthyroidism.
| Source: patient.co.uk |
| Clinical Resource: Article |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Investigation and Management of Amiodarone-Associated Thyroid Disease
| Source: nhslothian.scot.nhs.uk |
| Clinical Resource: Protocol |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
This article outlines changes to thyroid physiology and iodine requirements in pregnancy, pregnancy specific reference ranges for thyroid function tests and detection and management of thyroid conditions in pregnancy.
| Source: racgp.org.au |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 07/05/14 | Link Error: Report It |
Determining whether or not to treat individuals for hypothyroidism can be difficult in the population of the oldest old (those over 80 years of age) because the evidence base is limited and conflicting.
| Source: aging.arizona.edu |
| Clinical Resource: Factsheet |
| Register to Access Content: No |
| Last Checked: 26/10/15 | Link Error: Report It |
This column will focus on the relatively common condition known as subclinical hypothyroidism, also referred to as mild thyroid failure.
| Source: uspharmacist.com |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 25/06/13 | Link Error: Report It |
Subclinical hypothyroidism (SCH), also called mild thyroid failure, is diagnosed when peripheral thyroid hormone levels are within normal reference laboratory range but serum thyroid-stimulating hormone (TSH) levels are mildly elevated. This condition occurs in 3% to 8% of the general population. It is more common in women than men, and its prevalence increases with age. Of patients with SCH, 80% have a serum TSH of less than 10 mIU/L. The most important implication of SCH is high likelihood of progression to clinical hypothyroidism. The possibility that it is a cardiovascular risk factor has been a subject of debate.
| Source: mayoclinicproceedings.org |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 25/06/13 | Link Error: Report It |
Thyroxine tablets are important in managing hypothyroidism, but treatment may be sub-optimal if they are used incorrectly. The tablets have pharmaceutical properties which can impair the patients management. Discussing the correct use and storage of the tablets is an important part of prescribing thyroxine.
| Source: nps.org.au |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 08/08/16 | Link Error: Report It |
Levothyroxine is widely used to treat patients with thyroid disorders. Unfortunately, the bioavailability of levothyroxine can be reduced by a variety of other medications, leading to reduced levothyroxine effect.
| Source: hanstenandhorn.com |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 05/06/15 | Link Error: Report It |
Kelp is a generic term that refers to Laminaria and Macrocystis species of brown seaweeds, although in practice the term is often used in reference to species of Fucus. The species Fucus vesiculosus, more commonly known as bladderwrack, is reported to be commonly used in the preparation of kelp products. Because of its iodine content kelp has traditionally been used as a source of iodine for thyroid deficiency and as a slimming supplement.
| Source: sps.nhs.uk |
| Clinical Resource: Medicines Question and Answer |
| Register to Access Content: No |
| Last Checked: 22/09/16 | Link Error: Report It |
An expert clinical resource for women's healthcare. Constantly updated. Peer reviewed. Comprehensive coverage
Reproductive Endocrinology and Infertility
| Source: glowm.com |
| Clinical Resource: Library |
| Register to Access Content: No |
| Last Checked: 20/03/13 | Link Error: Report It |
Understanding the physiology of reproductive hormones, recognising pathology and knowing what tests to order, when to order them and how to interpret the results can be daunting. Hormone tests provide important information when applied appropriately, but often they are used without a clearly thought out diagnostic pathway, or in response to patient demand, rather than being tailored to the right patient in the right situation. In such situations, hormone tests will, at best, be of no clinical use, and at worst, lead to anxiety and uncertainty. We look at some of the more common applications of hormone tests in the general practice setting.
| Source: bpac.org.nz |
| Clinical Resource: Article |
| Register to Access Content: No |
| Last Checked: 13/03/14 | Link Error: Report It |
| Source: rcog.org.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 19/08/15 | Link Error: Report It |
| Source: rcog.org.uk |
| Clinical Resource: Scientific Impact Paper |
| Register to Access Content: No |
| Last Checked: 19/08/15 | Link Error: Report It |
Ovulation Induction in Polycystic Ovary Syndrome
This Clinical Practice Guideline has been prepared by the Reproductive Endocrinology and Infertility Committee and approved by Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.
| Source: sogc.org |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 19/10/15 | Link Error: Report It |
The North American Menopause Society Position Statements & Other Reports
| Source: menopause.org |
| Clinical Resource: Position Statements and Reports |
| Register to Access Content: No |
| Last Checked: 21/08/15 | Link Error: Report It |
International Menopause Society Recommendations
| Source: imsociety.org |
| Clinical Resource: Recommendations |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
International Menopause Society Position Papers and Consensus Statements
| Source: imsociety.org |
| Clinical Resource: Position Papers and Consensus Statements |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
This publication aims to help all health care professionals gain awareness of all these issues by reviewing what happens to the body during menopause and in the post-menopausal stage, examining the impact of these changes on women, and finally outlining the options for health after menopause.
| Source: rcn.org.uk |
| Clinical Resource: Guidance |
| Register to Access Content: No |
| Last Checked: 26/10/15 | Link Error: Report It |
This clinical practice guideline has been prepared by the Menopause and Osteoporosis Working Group, reviewed by the Clinical Practice Gynaecology and Family Physician Advisory Committees, and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.
| Source: sogc.org |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 19/10/15 | Link Error: Report It |
Fact Sheets
| Source: thebms.org.uk |
| Clinical Resource: Factsheets |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
The ASRM newsletter for clinicians who care for older women
| Source: asrm.org |
| Clinical Resource: Newsletters |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
This book is intended as a resource for family doctors and specialist nurses. It provides a concise account of recent advances in this exciting field, together with an outline of the evidence which informs current thinking. It is hoped that the information it contains will also prove useful to women interested in the up-to-date facts about HT. For the physician, prescription guidelines are included for women of different ages and clinical needs, highlighting the variety of treatment regimens currently in use.
| Source: imsociety.org |
| Clinical Resource: Book |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
The resources which are available for this therapeutic topic can be accessed via the menu on the left-hand side of the page. The e-learning home page suggests ways in which you may like to use the wide variety of e-learning materials.
| Source: webarchive.org.uk |
| Clinical Resource: e-Learning |
| Register to Access Content: No |
| Last Checked: 24/04/15 | Link Error: Report It |
All branded oral formulations of oestrogen-containing hormone replacement therapy (HRT) currently available on prescription contain lactose.
| Source: sps.nhs.uk |
| Clinical Resource: Medicines Question and Answer |
| Register to Access Content: No |
| Last Checked: 22/09/16 | Link Error: Report It |
| Source: rcog.org.uk |
| Clinical Resource: Scientific Impact Paper |
| Register to Access Content: No |
| Last Checked: 19/08/15 | Link Error: Report It |
There have been a great many trials of complementary and herbal medicines and some of these have suggested benefits from certain therapies and others have shown no benefit. It can be difficult for consumers and for doctors to interpret this mixed information. This information sheet provides a brief overview of the current evidence for complementary and herbal therapies.
| Source: menopause.org.au |
| Clinical Resource: Information Sheet |
| Register to Access Content: No |
| Last Checked: 29/11/16 | Link Error: Report It |
The guide provides details of the key cardiovascular risk factors in women and describes how risk can be determined and monitored within the gynaecological setting, and in which populations. The guide contains practical guidance for menopause physicians to follow to help them to reduce cardiovascular risk in their patients.
| Source: imsociety.org |
| Clinical Resource: Guide |
| Register to Access Content: No |
| Last Checked: 22/04/13 | Link Error: Report It |
The National Osteoporosis Guideline Group gratefully acknowledges the collaboration of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the support of the Bone Research Society, British Geriatrics Society, British Orthopaedic Association, Bone Research Society, British Society of Rheumatology, National Osteoporosis Society, Osteoporosis 2000, Osteoporosis Dorset, Primary Care Rheumatology Society, Royal College of Physicians and Society for Endocrinology.
| Source: shef.ac.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
| Source: iofbonehealth.org |
| Clinical Resource: Position Paper |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
| Source: nos.org.uk |
| Clinical Resource: Position Statement |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
| Source: sign.ac.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 28/09/17 | Link Error: Report It |
These courses encompass information from the causes and diagnosis of osteoporosis through to a review of treatment strategies. Advice on overcoming barriers to improved care is provided. The target audience of this programme is qualified physicians in secondary care and specialist primary care.
Course 1: Understanding bone metabolism
Course 2: Risk assessment and diagnostic techniques
Course 3: Management strategies for osteoporosis
Course 4: Fracture healing and osteoporosis
| Source: iofbonehealth.org |
| Clinical Resource: e-Learning |
| Register to Access Content: Yes - registration is FREE |
| Last Checked: 24/04/15 | Link Error: Report It |
The Clinician’s Guide to Prevention and Treatment of Osteoporosis was developed by an expert committee of the National Osteoporosis Foundation (NOF) in collaboration with a multispecialty council of medical experts in the field of bone health convened by NOF.
This Guide offers concise recommendations regarding prevention, risk assessment, diagnosis, and treatment of osteoporosis in postmenopausal women and men age 50 and older. It includes indications for bone densitometry and fracture risk thresholds for intervention with pharmacologic agents.
| Source: nof.org |
| Clinical Resource: Guide |
| Register to Access Content: No |
| Last Checked: 20/08/15 | Link Error: Report It |
Osteoporosis Update provides the most current, reliable information to support general practitioners and other health professionals involved in the daily clinical management of osteoporosis.
| Source: osteoporosis.ca |
| Clinical Resource: Periodical |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Osteoporosis Resources for Primary Care is a joint initiative of the National Osteoporosis Society and the Royal College of General Practitioners.
It seeks to provide GPs, Practice Nurses and other health professionals in the practice team with the clear, concise information they need to effectively manage osteoporosis and reduce fracture risk in older people.
| Source: osteoporosis-resources.org.uk |
| Clinical Resource: Guide |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Upon completion of this CE material, the participant should be able to:
| Source: nof.org |
| Clinical Resource: Update |
| Register to Access Content: No |
| Last Checked: 20/08/15 | Link Error: Report It |
| Source: esceo.org |
| Clinical Resource: Postion Paper |
| Register to Access Content: No |
| Last Checked: 23/10/15 | Link Error: Report It |
The role of calcium and vitamin D in the management of osteoporosis
The role of calcium and vitamin D supplementation in the treatment of osteoporosis has been extensively studied. The aim of this paper was to reach, where possible, consensus views on five key questions relating to calcium and vitamin D supplementation in the management of osteoporosis.
| Source: esceo.org |
| Clinical Resource: Paper |
| Register to Access Content: No |
| Last Checked: 20/08/15 | Link Error: Report It |
A document has been written which lists the available products for treating vitamin D deficiency and insufficiency, including cost, licensing status, and risk category.
| Source: sps.nhs.uk |
| Clinical Resource: Medicines Question and Answer |
| Register to Access Content: No |
| Last Checked: 22/09/16 | Link Error: Report It |
Reviewed and supported by the National Osteoporosis Society (NOS), the National Cancer Research Institute (NCRI) Breast Cancer Study Group and the International Osteoporosis Foundation (IOF)
| Source: nos.org.uk |
| Clinical Resource: Consensus Position Statement |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
This bulletin focuses on the pharmacological management of patients with post-menopausal osteoporosis - both those with clinically evident disease (e.g. prior osteoporotic fracture) and those who are identified as being at high-risk of fracture.
| Source: wemerec.org |
| Clinical Resource: Medicines Resource Centre Bulletin |
| Register to Access Content: No |
| Last Checked: 16/11/17 | Link Error: Report It |
This issue of “Osteoporosis Clinical Updates” provides tools and suggestions for identifying those CKD patients who would benefit from treatment for osteoporosis in a general practice setting and who would be better served by referral to a specialist with experience in renal-related bone disease.
| Source: nof.org |
| Clinical Resource: Update |
| Register to Access Content: No |
| Last Checked: 20/08/15 | Link Error: Report It |
Bone disease is commonly associated with chronic kidney disease (CKD), and the prevalence of skeletal abnormalities in those with end-stage renal disease approaches 100%. While renal osteodystrophy is the collective term for various types of uraemia-related bone remodelling, including hyperparathyroid bone disease, adynamic bone disease and osteomalacia, persons with CKD can also develop osteoporosis.
| Source: rcpe.ac.uk |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 17/02/14 | Link Error: Report It |
Bisphosphonate therapy is now the mainstay of treatment for patients with primary and secondary forms of osteoporosis. This class of drugs has earned this role because of multiple studies documenting the reduction in the incidence of vertebral and other fragility fractures in older women with osteoporosis at moderate to high fracture risk and the prevention of bone loss in many other medical conditions with bisphosphonate therapy. After beginning therapy, clinicians then confront the question of how long therapy should be continued.
| Source: sbdens.org.br |
| Clinical Resource: Publication |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
A. The bisphosphonates (alendronate, risedronate, and ibandronate) play an important role in the treatment and prevention of osteoporosis. Intravenous bisphosphonates (pamidronate and zoledronic acid) are also commonly used in the management of hypercalcemia associated with malignancy and in multiple myeloma. Although generally well tolerated, the long-term effect of these drugs on bone turnover has come into question.
| Source: duq.edu |
| Clinical Resource: Pharmaceutical Information Centre Publication |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Clinical Question: Can patients with osteoporosis who have been on bisphosphonates for 5 years discontinue treatment without increasing future fracture risk?
| Source: acfp.ca |
| Clinical Resource: Article |
| Register to Access Content: No |
| Last Checked: 21/08/15 | Link Error: Report It |
There has recently been considerable debate surrounding the required duration of treatment with bisphosphonates to produce the optimal antifracture activity without subjecting the patient to unnecessary treatment and its possible attendent adverse effects.
| Source: wemerec.org |
| Clinical Resource: Medicines Resource Centre E-Note |
| Register to Access Content: No |
| Last Checked: 16/11/17 | Link Error: Report It |
Update on Drug-Induced Osteoporosis (DIO)
Many commonly prescribed drugs are known to cause bone loss. The aim of this newsletter is to review drugs associated with osteoporosis (OP), the frequency of occurrence, prevention and management.
| Source: usask.ca |
| Clinical Resource: Drug Information Service Newsletter |
| Register to Access Content: No |
| Last Checked: 11/05/15 | Link Error: Report It |
As pituitary disease is relatively rare in the UK, a GP may only see one or two patients with the condition through his or her career.
Symptoms suffered by patients are wide-ranging and non-specific, and may not be recognised for some years. The GP Factfile aims to aid diagnostic skills and the shared after-care of patients.
Contents and Introduction
Introduction
A Guide to Pituitary Apoplexy
Non-functioning pituitary tumours
Acromegaly
Cushing’s disease
Hyperprolactinaemia
Hypopituitarism
Craniopharyngioma
Diabetes insipidus
Pituitary surgery
Radiotherapy
Hormone replacement therapy
Hypogonadism
Psychological Issues
Referrals – Who and When to refer
Resource list
| Source: pituitary.org.uk |
| Clinical Resource: Factsheets |
| Register to Access Content: Yes - registration is FREE |
| Last Checked: 31/05/13 | Link Error: Report It |
The Neuroendocrine Clinical Center - A multidisciplinary approach to patients with pituitary and hypothalamic disorders. Including the Neuroendocrine Center Bulletin; A newsletter with information regarding pituitary tumors. Information on acromegaly, Cushing's disease or syndrome, prolactinoma, chromophobe or nonfunctioning pituitary adenoma, and thyrotroph adenomas.
| Source: pituitary.mgh.harvard.edu |
| Clinical Resource: Various |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Contraceptive Options for Women with Prolactinoma
Faculty of Sexual & Reproductive Healthcare
| Source: fsrh.org |
| Clinical Resource: Statement |
| Register to Access Content: No |
| Last Checked: 10/06/15 | Link Error: Report It |
This leaflet, Diagnosing Addison's, outlines the role of the GP in the early detection of Addison's. It has been developed for the Addison's Disease Self Help Group by our Clinical Advisory Panel and covers:
| Source: addisons.org.uk |
| Clinical Resource: Leaflet |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
The leaflet outlines the role of the GP in managing Addison’s disease at each stage in the patient lifecycle from diagnosis to old age. It is two A4 sides long and covers:
| Source: addisons.org.uk |
| Clinical Resource: Leaflet |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
The surgical guidelines have been developed for the Addison's Disease Self Help Group by our Clinical Advisory Panel.
These guidelines:
a. List the ten main types of surgical procedure, each requiring a different level of peri-operative steroid cover
b. Specify the glucocorticoid medication and post-operative treatment requirements for each type of procedure in an easy-to-read table
c. Bring together on the timing and the most efficient route for administration of steroid cover during the stress of surgical procedures.
d. Suggest a risk-free level of steroid cover, that should be sufficient for a patient with additional health complications.
| Source: addisons.org.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Adrenal response to stress can vary broadly from patient to patient. For hospitalists, the challenge is predicting patients’ cortisol needs.
| Source: the-hospitalist.org |
| Clinical Resource: Article |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Guideline for Perioperative Steroid Replacement
Royal Cornwall Hospitals NHS Trust
The purpose of this guideline is to provide a framework for the safe management of patients in the peri-operative period who have been prescribed steroid medications.
| Source: rcht.nhs.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 22/11/13 | Link Error: Report It |
This review offers an approach to identifying and managing corticosteroid-induced psychiatric syndromes based on the type of symptoms and anticipated duration of corticosteroid treatment.
| Source: mayoclinicproceedings.org |
| Clinical Resource: Journal Article |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Glucocorticoids such as prednisolone and hydrocortisone have long been known to increase blood glucose levels. They do not seem to interfere with glucose uptake by the cell, but probably interfere with one or more of the intracellular mechanisms of glucose metabolism or insulin resistance.
| Source: auspharmlist.net.au |
| Clinical Resource: Pharmacy E-Bulletin |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
This document presents evidence-based guidelines for the management of glucocorticoidinduced osteoporosis.
| Source: nos.org.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Corticosteroids are widely used in primary care. The main conditions requiring them include rheumatoid arthritis, polymyalgia rheumatica, inflammatory bowel disease and asthma/chronic obstructive airways disease, and around 0.5% of the UK adult population currently take oral corticosteroids. Although therapeutically effective, their long-term use is associated with considerable morbidity and possibly also premature mortality, for example through accelerated atherosclerosis. In the locomotor system, however, the principal steroid complication is the development of osteoporosis.
| Source: arthritisresearchuk.org |
| Clinical Resource: Report |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
As the debate continues about whether the EC formulation provides gastro-protection compared with the uncoated tablets, in addition to the cost differential of the two products (three-fold difference at time of writing based on Drug Tariff June 2013), a summary of the findings of the DTB and an update of the literature with a focus on the implications of switching formulations are presented
| Source: sps.nhs.uk |
| Clinical Resource: Medicines Question and Answer |
| Register to Access Content: No |
| Last Checked: 22/09/16 | Link Error: Report It |
A statement produced by:
British Society for Sexual Medicine
In association with:
British Association for Sexual Health and HIV
British Association of Urological Surgeons
British Fertility Society
British Menopause Society
Royal College of Pathologists
Royal College of Physicians
Society for Endocrinology
| Source: bssm.org.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
A statement produced by:
British Society for Sexual Medicine
In association with:
British Association for Sexual Health and HIV
British Association of Urological Surgeons
British Fertility Society
British Menopause Society
Royal College of Pathologists
Royal College of Physicians
Society for Endocrinology
| Source: bssm.org.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
This document has been reviewed by the Reproductive Endocrinology Infertility Committee and approved by Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.
| Source: sogc.org |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 19/10/15 | Link Error: Report It |
European Association for the Study of Obesity Guidelines
| Source: easo.org |
| Clinical Resource: Guidelines |
| Register to Access Content: No |
| Last Checked: 21/08/15 | Link Error: Report It |
Obesity Society Position Statements
| Source: obesity.org |
| Clinical Resource: Position Statements |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Scottish Intercollegiate Guidelines Network (SIGN) Guideline > Management of Obesity
| Source: sign.ac.uk |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 28/09/17 | Link Error: Report It |
The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults
This Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults was developed cooperatively by the North American Association for the Study of Obesity (NAASO) and the National Heart, Lung, and Blood Institute (NHLBI).
| Source: obesity.org |
| Clinical Resource: Publication |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
| Source: cmaj.ca |
| Clinical Resource: Guideline |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
Resources and training to support healthcare professionals
| Source: nationalobesityforum.org.uk |
| Clinical Resource: Various |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
The resources which are available for this therapeutic topic can be accessed via the menu on the left-hand side of the page. The e-learning home page suggests ways in which you may like to use the wide variety of e-learning materials.
| Source: webarchive.org.uk |
| Clinical Resource: e-Learning |
| Register to Access Content: No |
| Last Checked: 24/04/15 | Link Error: Report It |
This article will focus on the type of metabolic abnormalities that can be associated with AAPs as well as recommended monitoring and management strategies.
| Source: oregonstate.edu |
| Clinical Resource: Newsletter |
| Register to Access Content: No |
| Last Checked: 19/08/15 | Link Error: Report It |
The database contains expert assessments of the potential of drugs to provoke attacks of acute porphyria. The database provides guidance based on a very careful evaluation of international clinical experience, published case reports, previously published drug lists, and theoretical considerations.
| Source: drugs-porphyria.org |
| Clinical Resource: Database |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
For healthcare professionals
Drugs and acute porphyrias
| Source: porphyria-europe.com |
| Clinical Resource: Various |
| Register to Access Content: No |
| Last Checked: 08/05/13 | Link Error: Report It |
These pages are written in the detail and using the terminology required for doctors and other health professionals. A full explanation of porphyria is given, as well as practical details of diagnosis and management.
You will also find a range of useful additional information difficult to source elsewhere, such as guidelines for the management of specific diseases in the presence of porphyria, on ordering haem arginate, on pregnancy and delivery and so on.
| Source: porphyria.uct.ac.za |
| Clinical Resource: Various |
| Register to Access Content: No |
| Last Checked: 20/08/15 | Link Error: Report It |
|
